Document Detail


Glomerular protein levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 are lower in diabetic subjects.
MedLine Citation:
PMID:  19506087     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) regulate extracellular matrix turnover throughout the body, including in renal glomeruli. We investigated protein levels of multiple MMPs (MMP-1, MMP-2, MMP-3, and MMP-9) and TIMP-1 in glomeruli and investigated whether disease phenotypes were associated with levels of these proteins. Renal cortex was collected from 100 adult autopsy subjects arrayed across 17 tissue microarrays. Immunohistochemical staining intensity for each MMP and TIMP-1 was determined using quantitative color deconvolution techniques. We observed significantly decreased glomerular MMP-1 and TIMP-1 staining in subjects with diabetes, hypertension, and an estimated glomerular filtration rate <30 ml/min/1.73 m(2) in univariate analyses. MMP-1 staining, but not TIMP-1 staining, was inversely correlated with increased glomerular fibrosis (r = -0.40). In multivariable analysis, diabetes was robustly associated with decreased staining intensity. This study indicates that in human subjects, the long-term sequelae of diseases such as diabetes that cause chronic renal failure result in decreased TIMP-1 and MMP-1 proteins in renal glomeruli. This manuscript contains online supplemental material at http://www.jhc.org. Please visit this article online to view these materials.
Authors:
Toby C Cornish; Serena M Bagnasco; Anne M Macgregor; Jie Lu; Elizabeth Selvin; Marc K Halushka
Related Documents :
2612717 - Hypertension and microalbuminuria as predictors of diabetic nephropathy.
8793227 - Are glomerular lesions alternatives to microalbuminuria in predicting later progression...
12924617 - Remission and regression of diabetic nephropathy.
12595507 - Delayed treatment with lithospermate b attenuates experimental diabetic renal injury.
19440117 - Autoimmune forms of hypoglycemia.
12445887 - Physiological concentrations of insulin induce endothelin-mediated vasoconstriction dur...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2009-06-08
Journal Detail:
Title:  The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society     Volume:  57     ISSN:  1551-5044     ISO Abbreviation:  J. Histochem. Cytochem.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-19     Completed Date:  2009-11-17     Revised Date:  2011-09-07    
Medline Journal Info:
Nlm Unique ID:  9815334     Medline TA:  J Histochem Cytochem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  995-1001     Citation Subset:  IM    
Affiliation:
Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Analysis of Variance
Antibodies / immunology
Color
Diabetes Mellitus / metabolism*,  pathology,  physiopathology
Female
Fibrosis / complications
Humans
Immunohistochemistry
Kidney Diseases / complications
Kidney Glomerulus / metabolism*,  pathology
Male
Matrix Metalloproteinase 1 / immunology,  metabolism*
Middle Aged
Staining and Labeling
Tissue Array Analysis
Tissue Inhibitor of Metalloproteinase-1 / immunology,  metabolism*
Young Adult
Grant Support
ID/Acronym/Agency:
K-01 DK-076595/DK/NIDDK NIH HHS; K01 DK076595-01/DK/NIDDK NIH HHS; K01 DK076595-02/DK/NIDDK NIH HHS; K01 DK076595-03/DK/NIDDK NIH HHS; K01 DK076595-04/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Antibodies; 0/Tissue Inhibitor of Metalloproteinase-1; EC 3.4.24.7/Matrix Metalloproteinase 1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Development of Goal-Sensitive Health-Related Utility Assessment Procedures.
Next Document:  Cell Death-associated ADAMTS4 and Versican Degradation in Vascular Tissue.